JPRN-UMIN000004426已完成未知
Clinical significance of arbekacin for MRSA infection in patients with hematological malignancies based on the PK-PD index - Clinical significance of arbekacin for MRSA infection in patients with hematological malignancies
ihon University School of Medicine0 个研究点目标入组 100 人开始时间: 2010年10月22日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Patients who have received any other anti-MRSA agents (vancomycin, teicoplanin, linezolid) within 2 weeks before administration of arbekacin. 2) Patients with reduced renal function (creatinine clearance, 30 mL/min/1.73 m2 or less). 3) Patients who are pregnant or might be pregnant. 4) Patients with a medical history or a family history of deafness induced by aminoglycoside antibiotics, or other patients with deafness. 5) Patients on any form of dialysis (hemodialysis: HD; continuous ambulatory peritoneal dialysis: CAPD; continuous hemodiafiltration, CHDF). 6) Patients deemed unsuitable for enrollment by the physician in charge for any other reason.
研究者
相似试验
已完成
不适用
Efficacy and safety of anti-MRSA antibiotics for hospital-acquired pneumonia: a systematic review and meta-analysisHospital-acquired pneumoniaJPRN-UMIN000048776HO Kinki-chuo Chest Medical Center
已完成
2 期
Performance eradication of Staphylococcus aureus with mupirocin in nasal personnel ICU ward.IRCT2014102519666N1Vice Chancellor for Research and Technology, Golestan University of Medical Sciences240
已完成
不适用
MESS-study MRSA Eradication Study SkåneThroatcarriers of MRSANCT01269541Region Skane69
进行中（未招募）
1 期
Treatment of patients with MRSA bacteria in their throat by irrigation with the drug mupirociPatientents being MRSA positive for a minimum of 6 months and concluded at least one konventional topical treatments unsuccessfullyMedDRA version: 20.0Level: PTClassification code 10061554Term: Staphylococcal pharyngitisSystem Organ Class: 10021881 - Infections and infestationsEUCTR2014-005308-12-DKRegion Sjælland, Slagelse Hospital20
No Longer Available
不适用
Arbekacin Treatment of Adult Patients With Infections Caused by Multidrug-resistant BacteriaInfection Due to Resistant OrganismNCT01659515U.S. Army Medical Research and Development Command